These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 426839)

  • 21. Role of isosafrole as complexing agent and inducer of P-450LM4 in rabbit liver microsomes.
    Delaforge M; Koop DR; Coon MJ
    Biochem Biophys Res Commun; 1982 Sep; 108(1):59-65. PubMed ID: 6816232
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterization of a metabolite-cytochrome P-450 complex derived from the aerobic metabolism of an insect juvenile hormone analog by rat microsomal fractions.
    Mayer RT; Prough RA
    Toxicol Appl Pharmacol; 1976 Nov; 38(2):439-54. PubMed ID: 11574
    [No Abstract]   [Full Text] [Related]  

  • 23. Possible pitfalls of the biphenyl test for chemical carcinogens [proceedings].
    Tong S; Ioannides C; Parke DV
    Biochem Soc Trans; 1977; 5(5):1372-4. PubMed ID: 923936
    [No Abstract]   [Full Text] [Related]  

  • 24. Metabolic-intermediate complex formation reveals major changes in rat hepatic cytochrome P-450 subpopulations in addition to those forms previously purified after phenobarbital, beta-naphthoflavone, and isosafrole induction.
    Bornheim LM; Franklin MR
    Mol Pharmacol; 1982 Mar; 21(2):527-32. PubMed ID: 7099151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of safrole and isosafrole pretreatment on N- and ring-hydroxylation of 2-acetamidofluorene by the rat and hamster.
    Lotlikar PD; Wasserman MB
    Biochem J; 1972 Oct; 129(4):937-43. PubMed ID: 4655827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the substrate-binding sites of liver microsomal cytochrome P-448.
    Phillipson CE; Ioannides C; Delaforge M; Parke DV
    Biochem J; 1982 Oct; 207(1):51-6. PubMed ID: 7181861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amino-terminal and carboxy-terminal sequence of hepatic microsomal cytochrome P-450d, a unique hemoprotein from rats treated with isosafrole.
    Botelho LH; Ryan DE; Yuan PM; Kutny R; Shively JE; Levin W
    Biochemistry; 1982 Mar; 21(6):1152-5. PubMed ID: 7074072
    [No Abstract]   [Full Text] [Related]  

  • 28. Characterization of the biliary and urinary glutathione and N-acetylcysteine metabolites of the hepatic carcinogen 1'-hydroxysafrole and its 1'-oxo metabolite in rats and mice.
    Fennell TR; Miller JA; Miller EC
    Cancer Res; 1984 Aug; 44(8):3231-40. PubMed ID: 6744260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of safrole and isosafrole with hepatic microsomal haemoproteins.
    Lake BG; Parke DV
    Biochem J; 1972 Apr; 127(2):23P. PubMed ID: 4403948
    [No Abstract]   [Full Text] [Related]  

  • 30. A novel haemoprotein induced by isosafrole pretreatment in the rat.
    Dickins M; Bridges JW; Elcombe CR; Netter KJ
    Biochem Biophys Res Commun; 1978 Jan; 80(1):89-96. PubMed ID: 623660
    [No Abstract]   [Full Text] [Related]  

  • 31. Interaction of isosafrole in vivo with rat hepatic microsomal cytochrome P-450 following treatment with phenobarbitone or 20-methylcholanthrene.
    Fennell TR; Dickins M; Bridges JW
    Biochem Pharmacol; 1979 Apr; 28(8):1427-9. PubMed ID: 444308
    [No Abstract]   [Full Text] [Related]  

  • 32. Structure--activity relationship for 'safrole-type' cytochrome P-450 induction [proceedings].
    Fennell TR; Bridges JW
    Biochem Soc Trans; 1979 Oct; 7(5):1104-6. PubMed ID: 510716
    [No Abstract]   [Full Text] [Related]  

  • 33. Induction of phencyclidine metabolism by phencyclidine, ketamine, ethanol, phenobarbital and isosafrole.
    Kammerer RC; Schmitz DA; Hwa JJ; Cho AK
    Biochem Pharmacol; 1984 Feb; 33(4):599-604. PubMed ID: 6704176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevention of CCl4-induced liver necrosis in mice by naturally occurring methylenedioxybenzenes.
    Zhao ZS; O'Brien PJ
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):411-21. PubMed ID: 8887459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of puromycin on binding and on metabolism in vitro of substrates by rat liver microsomes.
    Soliman MR; Wade AE
    Biochem Pharmacol; 1972 Oct; 21(19):2652-6. PubMed ID: 4661623
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolism of safrole in the rat.
    Klungsøyr J; Scheline RR
    Acta Pharmacol Toxicol (Copenh); 1983 Mar; 52(3):211-6. PubMed ID: 6846029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice.
    Randerath K; Haglund RE; Phillips DH; Reddy MV
    Carcinogenesis; 1984 Dec; 5(12):1613-22. PubMed ID: 6499112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biphasic responses in synergistic interactions.
    Hodgson E; Ryu DY; Adams N; Levi PE
    Toxicology; 1995 Dec; 105(2-3):211-6. PubMed ID: 8571358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human cytochrome p450 enzyme specificity for bioactivation of safrole to the proximate carcinogen 1'-hydroxysafrole.
    Jeurissen SM; Bogaards JJ; Awad HM; Boersma MG; Brand W; Fiamegos YC; van Beek TA; Alink GM; Sudhölter EJ; Cnubben NH; Rietjens IM
    Chem Res Toxicol; 2004 Sep; 17(9):1245-50. PubMed ID: 15377158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro biotransformation of xanthohumol, a flavonoid from hops (Humulus lupulus), by rat liver microsomes.
    Yilmazer M; Stevens JF; Deinzer ML; Buhler DR
    Drug Metab Dispos; 2001 Mar; 29(3):223-31. PubMed ID: 11181488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.